Tobias E. Larsson

Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia

Kenneth B. Jonsson, R Zahradnik, Tobias E. Larsson et al. · New England Journal of Medicine · 2003 · 907 citations · Full text

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

Tobias E. Larsson, Ulf Nisbeth, Östen Ljunggren et al. · Kidney International · 2003 · 686 citations

Metabolic Syndrome, Nutrition, Urology +11

Transgenic Mice Expressing Fibroblast Growth Factor 23 under the Control of the α1(I) Collagen Promoter Exhibit Growth Retardation, Osteomalacia, and Disturbed Phosphate Homeostasis

Tobias E. Larsson, Richard Marsell, Ernestina Schipani et al. · Endocrinology · 2004 · 496 citations

Human Growth, Pathology, Osteoporosis +17

Fibroblast growth factor-23 regulates parathyroid hormone and 1α-hydroxylase expression in cultured bovine parathyroid cells

Tijana Krajisnik, Peyman Björklund, Richard Marsell et al. · Journal of Endocrinology · 2007 · 469 citations · Full text

Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community

Emil Hagström, Per Hellman, Tobias E. Larsson et al. · Circulation · 2009 · 405 citations · Full text